YEARS

2011-2014

AUTHORS

Mousumi Banerjee

TITLE

Machine Learning Tools for Prognostication in Melanoma

ABSTRACT

DESCRIPTION (provided by applicant): The purpose of the study is to develop and validate a tool for reliable individualized prognostication of Stage III melanoma patients for use in the clinical setting. Cutaneous melanoma is the sixth most common cancer in the United States, and its incidence rate is increasing faster than any other cancer. Nearly 69,000 new cases are expected be diagnosed in this country in 2010. While thin melanomas are typically cured with excision alone, thicker melanomas have a greater tendency to metastasize to the regional lymph nodes. A diagnosis of Stage III melanoma is made if there is spread to the regional lymph nodes. Unfortunately, there is marked diversity in the natural history of Stage III melanoma, and outcomes within this group are extremely heterogeneous, with 5- year survival rates ranging from 23% to 87%. Similarly, treatment options range from intensive forms of systemic therapy to observation. Understanding patients' differences in clinical outcome is critical not only for calibrating therapeutic intensity to metastatic risk but also in the design and analysis of clinical trials. There is a real void of reliable prognostic tools for Stage III melanoma. Based on novel machine learning approaches, the purpose of this study will be to develop and validate a reliable and individualized tool for prognostication of Stage III melanoma patients that can be used in the clinical setting.

FUNDED PUBLICATIONS

  • Tree-based model for thyroid cancer prognostication.
  • How to use: Click on a object to move its position. Double click to open its homepage. Right click to preview its contents.

    Download the RDF metadata as:   json-ld nt turtle xml License info


    18 TRIPLES      17 PREDICATES      19 URIs      9 LITERALS

    Subject Predicate Object
    1 grants:2ab9753a1fc52742782d7974530082b3 sg:abstract DESCRIPTION (provided by applicant): The purpose of the study is to develop and validate a tool for reliable individualized prognostication of Stage III melanoma patients for use in the clinical setting. Cutaneous melanoma is the sixth most common cancer in the United States, and its incidence rate is increasing faster than any other cancer. Nearly 69,000 new cases are expected be diagnosed in this country in 2010. While thin melanomas are typically cured with excision alone, thicker melanomas have a greater tendency to metastasize to the regional lymph nodes. A diagnosis of Stage III melanoma is made if there is spread to the regional lymph nodes. Unfortunately, there is marked diversity in the natural history of Stage III melanoma, and outcomes within this group are extremely heterogeneous, with 5- year survival rates ranging from 23% to 87%. Similarly, treatment options range from intensive forms of systemic therapy to observation. Understanding patients' differences in clinical outcome is critical not only for calibrating therapeutic intensity to metastatic risk but also in the design and analysis of clinical trials. There is a real void of reliable prognostic tools for Stage III melanoma. Based on novel machine learning approaches, the purpose of this study will be to develop and validate a reliable and individualized tool for prognostication of Stage III melanoma patients that can be used in the clinical setting.
    2 sg:endYear 2014
    3 sg:fundingAmount 353775.0
    4 sg:fundingCurrency USD
    5 sg:hasContribution contributions:634e84685917b94719a661c49623f963
    6 sg:hasFieldOfResearchCode anzsrc-for:11
    7 anzsrc-for:1112
    8 sg:hasFundedPublication articles:ba43ddb995e4e2b380f8c1a8274e22eb
    9 sg:hasFundingOrganization grid-institutes:grid.48336.3a
    10 sg:hasRecipientOrganization grid-institutes:grid.214458.e
    11 sg:language English
    12 sg:license http://scigraph.springernature.com/explorer/license/
    13 sg:scigraphId 2ab9753a1fc52742782d7974530082b3
    14 sg:startYear 2011
    15 sg:title Machine Learning Tools for Prognostication in Melanoma
    16 sg:webpage http://projectreporter.nih.gov/project_info_description.cfm?aid=8335369
    17 rdf:type sg:Grant
    18 rdfs:label Grant: Machine Learning Tools for Prognostication in Melanoma
    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular JSON format for linked data.

    curl -H 'Accept: application/ld+json' 'http://scigraph.springernature.com/things/grants/2ab9753a1fc52742782d7974530082b3'

    N-Triples is a line-based linked data format ideal for batch operations .

    curl -H 'Accept: application/n-triples' 'http://scigraph.springernature.com/things/grants/2ab9753a1fc52742782d7974530082b3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'http://scigraph.springernature.com/things/grants/2ab9753a1fc52742782d7974530082b3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'http://scigraph.springernature.com/things/grants/2ab9753a1fc52742782d7974530082b3'






    Preview window. Press ESC to close (or click here)


    ...